-
EP4248970
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4248970
| EP4248970 - OPTHALMIC COMPOSITIONS COMPRISING CETIRIZINE AND TOCOFERSOLAN [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 20.10.2023 Database last updated on 19.10.2024 | |
| Former | Request for examination was made Status updated on 25.08.2023 | ||
| Former | The international publication has been made Status updated on 27.05.2022 | Most recent event Tooltip | 20.10.2023 | Withdrawal of application | published on 22.11.2023 [2023/47] | Applicant(s) | For all designated states Taejoon Pharmaceutical Co., Ltd. 8 Daesagwan-ro 31-gil Yongsan-gu Seoul 04401 / KR | [2023/39] | Inventor(s) | 01 /
LEE, Joon Youb Seoul 04401 / KR | 02 /
RYU, Sang Rok Suwon-si Gyeonggi-do 16509 / KR | 03 /
KIM, Han Gyeol Suwon-si Gyeonggi-do 16498 / KR | [2023/39] | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [2023/39] | Application number, filing date | 21895102.8 | 17.11.2021 | [2023/39] | WO2021KR16900 | Priority number, date | KR20200154712 | 18.11.2020 Original published format: KR 20200154712 | [2023/39] | Filing language | KO | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022108334 | Date: | 27.05.2022 | Language: | KO | [2022/21] | Type: | A1 Application with search report | No.: | EP4248970 | Date: | 27.09.2023 | Language: | EN | [2023/39] | Search report(s) | International search report - published on: | KR | 27.05.2022 | Classification | IPC: | A61K31/496, A61K31/355, A61K9/00, A61P27/02, A61P27/14 | [2023/39] | CPC: |
A61P27/02 (EP);
A61K9/0048 (EP,KR);
A61K31/4745 (EP);
A61K31/495 (EP,KR);
A61K47/22 (EP,KR);
A61K9/08 (EP);
A61P27/14 (KR)
(-)
| C-Set: |
A61K31/4745, A61K2300/00 (EP);
A61K31/495, A61K2300/00 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/39] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | CETIRIZIN UND TOCOFERSOLAN ENTHALTENDE OPTHALMISCHE ZUSAMMENSETZUNGEN | [2023/39] | English: | OPTHALMIC COMPOSITIONS COMPRISING CETIRIZINE AND TOCOFERSOLAN | [2023/39] | French: | COMPOSITIONS OPHTALMIQUES COMPRENANT DE LA CÉTIRIZINE ET DU TOCOFERSOLAN | [2023/39] | Entry into regional phase | 09.06.2023 | Translation filed | 09.06.2023 | National basic fee paid | 09.06.2023 | Search fee paid | 09.06.2023 | Designation fee(s) paid | 09.06.2023 | Examination fee paid | Examination procedure | 09.06.2023 | Examination requested [2023/39] | 16.10.2023 | Application withdrawn by applicant [2023/47] |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US5558876 (DESAI SUKETU [US], et al) [A] 1-8,10-11 * See entire document. *; | [A]CN1785192 (HU SHIXING [CN]) [A] 1-8,10-11 * See entire document. *; | [A]US2010144718 (NICOLAOU MICHALIS [US], et al) [A] 1-8,10-11 * See entire document. *; | [X]KR20200018580 (EYE THERAPIES LLC [US]) [X] 1-8,10-11 * See paragraphs [0011], [0029] and [0036]; and claims 18-22. *; | [PX]US2021299121 (SHAH MANDAR V [US], et al) [PX] 1-2,4-6,10-11* See abstract; paragraphs [0012], [0014] and [0056]-[0057]; and claims 1 and 3. * |